Press Release Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares 1 hour ago
Press Release Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates Aug 6
Press Release Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 3